-
Robert Yarchoan (born 1950) is a
medical researcher who pla**** an
important role in the
development of the
first effective drugs for AIDS. He is the Chief...
-
developed as an anti-HIV
agent by
Samuel Broder,
Hiroaki Mitsuya, and
Robert Yarchoan at the
National Cancer Institute (NCI). Like didanosine, it was then licensed...
- humans.
Shortly thereafter,
Samuel Broder,
Hiroaki Mitsuya, and
Robert Yarchoan of the
United States National Cancer Institute (NCI)
initiated a program...
-
Robins in 1964. Subsequently,
Samuel Broder,
Hiroaki Mitsuya, and
Robert Yarchoan in the
National Cancer Institute (NCI)
found that ddA and ddI
could inhibit...
- PMID 7700311. Goncalves,
Priscila H.; Ziegelbauer, Joseph; Uldrick,
Thomas S.;
Yarchoan,
Robert (2017). "Kaposi
sarcoma herpesvirus-****ociated
cancers and related...
- Cancer. 2 (5): 373–82. doi:10.1038/nrc797. PMID 12044013. S2CID 13513517.
Yarchoan R,
Tosato G,
Little RF (August 2005). "Therapy insight: AIDS-related malignancies...
-
Toschi E,
Palladino C,
Barillari G,
Carlei D,
Cereseto A,
Ciccolella C,
Yarchoan R,
Monini P, Stürzl M,
Ensoli B (July 2000). "Mechanism of pa****axel activity...
- Cancer. 2 (5): 373–382. doi:10.1038/nrc797. PMID 12044013. S2CID 13513517.
Yarchoan R,
Tosato G,
Little RF (2005). "Therapy insight: AIDS-related malignancies...
-
Study of
Liver Diseases.
Retrieved 16 July 2024.
Singal AG,
Llovet JM,
Yarchoan M,
Mehta N,
Heimbach JK,
Dawson LA, et al. (2023). "AASLD
Practice Guidance...
- Baghdadi, Azarakhsh; Kamel, Ihab R.; Simon,
Sanford M.; Migler,
Rachael D.;
Yarchoan, Mark (30
October 2022). "Clinical
Outcomes in
Fibrolamellar Hepatocellular...
